 |
 |
 |
 |
 |
Institution
Ø We partner with global healthcare corporations to design and execute all phase clinical trials and outcomes research aiming to better define unmet medical needs and maximize values of medical innovations.
Ø We collaborate with academic and government organizations to conduct population based research aiming to improve evidence based medicine and deliver disease management solutions.
Recent Events and Links
Speakers at 2nd CCMR sympsoium
Industry panel at 2nd CCMR symposium
Latest News
September 2010
VSRI Chief Medical Officer is invited to speak at the Oncology Clinical Trials in Emerging Markets conference. More about VSRI research and service in China.
August 2010
VSRI proudly introduces its web-based Study Center providing investigators and sponsors 24/7 support and information regarding ongoing and completed clinical studies that VSRI leads or manages; it also provides a portal to the latest research and findings in the literature and news media as well as a secured access to VSRI proprietary eCRF...More
July 2010
VSRI has launched the largest outcomes research study in China - "
Nationwide Assessment of Cardiovascular Risk Factors: Blood Pressure, Blood Lipid, and Blood Glucose, in Chinese Patients with Type 2 Diabetes", which will recruit 25,000 patients...More
VSRI will showcase it extensive experience in clinical trial managment and regulatory affairs in China for oncology products a ASCO 2010 on June 5-8....More.
May, 2010
CMDA (Chinese Medical Doctor Association) and VSRI have jointly formed a Coalition for Clinical Research in Cardiovascular and Metabolic Diseases (CCRC). See News Release in English or Chinese.
April, 2010
VSRI will showcase its unique customized research model, above and beyond the traditional contract research model, at ACRP 2010, to be held in Tampa, FL on April 23-27.
March, 2010
VSRI has lanched one of the largest cohort studies in Type 2 diabetes, targeting to enroll 25,000 patients across all 6 geographic regions in China...More
December, 2009
VSRI received a research grant from Roche Pharmaceutical Development Center in Asia/Pacific to conduct an outcomes research study in type 2 diabetes in China...More
November, 2009
VSRI sponsors "3rd Annual Evidence-Based Medicine and Comparative Effectiveness Research Summit for the Bio/Pharmaceutical and Medical Device Industries", November 17-18, Philadelphia, PA...More
Article "CCMR Holds 2nd Annual Symposium to Further Evidence-Based Medicine in China", written by VSRI Chief Medical Officer has been published in Pharma China Web Edition on November 6, 2009...More
October, 2009
Full house attendance at the VSRI co-sponsored 2nd Annual China Cardiometatolic Regisitries (CCMR) Symposium...More
September, 2009 We are pleased to announce the Grand Opening of our new office in Shanghai China. The bigger space better suits us for an expanded operation...More May, 2009 March, 2009 February, 2009 January, 2009 December, 2008 Johnson & Johnson Pharmaceutical Research and Development has become CCMR corporate silver sponsor.
VSRI is to co-organize the 2nd Annual China Cardiometabolic Registries (CCMR) Symposium in Beijing, China, on October 9, 2009...More
Bristrol Myers Squibb and INC Research have become the proud sponsors to the 2nd annual CCMR symposium, that VSRI co-organizes.
June, 2009
VSRI will give a lecture on the topic of "Clinical Research and Product Registration in China" on FOI conference.....More
VSRI and Fudan University, Evidence Based Medicine Research Center co-sponsored an international lecture...More
VSRI and CCMR committees successfully organized a MindXchange Forum, where medical leaders met with industry leaders, This was the biginning of a new paradigm...More
Chief Medical Officer, Dr. Danyi Zhang spoke at Sino- American Pharmaceutical Professionals Association Conference. Click to see program.
Announcing innovative forum, MindXchange Between Industry and Medical Leaders, May 14, 2009, Beijing, China.
Announcing 2nd China Cardiometabolic Registries (CCMR) symposium, October 9, 2009, Beijing, China
VitalStrategic Research Institute has formed a joint research center with Fudan University, School of Public Health, Shanghai, China, focusing on evidence-based medical research.
Roche Pharma Development Center in China, Shanghai Roche Pharmacetuical Ltd. has become the first CCMR corporate sponsor.
 |
 |
 |
 |
| Site Map |